Efficacy and safety of interleukin-17 antagonists in patients with plaque psoriasis: a meta-analysis from phase 3 randomized controlled trials
Author:
Affiliation:
1. Second Departments of Rheumatology; Shengjing Hospital of China Medical University; Shenyang Liaoning China
2. Intensive Care Unit; The People's Hospital of Liaoning Province; Shenyang Liaoning China
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14125/fullpdf
Reference52 articles.
1. Latitude and psoriasis prevalence;Jacobson;J Am Acad Dermatol,2011
2. Quality of life in patients with psoriasis: a systematic literature review;Korte;J Investig Dermatol Symp Proc,2004
3. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction;Stern;J Investig Dermatol Symp Proc,2004
4. European S3-guidelines on the systemic treatment of psoriasis vulgaris;Pathirana;J Eur Acad Dermatol Venereol,2009
5. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial;Reich;Lancet,2005
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Impact of Interleukin-17 Inhibitors on Major Adverse Cardiovascular Events in Psoriasis or Psoriatic Arthritis Patients Naive to Biologic Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Cureus;2024-05-24
2. Association of IL-17 Inhibitors with Hypertension in Patients with Autoimmune Diseases: A Systematic Review and Meta-analysis on Randomized Controlled Trials;Journal of Cardiovascular Pharmacology;2024-02-27
3. Risk of stroke in patients with psoriatic disease: a systematic review and meta-analysis;2023-10-27
4. An Evaluation of Spin in the Abstracts of Systematic Reviews and Meta-analyses on the Treatment of Psoriasis: A Cross-sectional Analysis;Cutis;2023-05
5. Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis;Frontiers in Pharmacology;2021-11-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3